Use of a Recombinant Cysteine Proteinase from Leishmania (Leishmania) infantum chagasi for the Immunotherapy of Canine Visceral Leishmaniasis

BACKGROUND: A recombinant cysteine proteinase from Leishmania (Leishmania) infantum chagasi (rLdccys1) was previously shown to induce protective immune responses against murine and canine visceral leishmaniasis. These findings encouraged us to use rLdccys1 in the immunotherapy of naturally infected...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Josie Haydée Lima, Silva, Lucilene dos Santos, Longo-Maugéri, Ieda Maria, Katz, Simone, Barbiéri, Clara Lúcia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953064/
https://www.ncbi.nlm.nih.gov/pubmed/24625516
http://dx.doi.org/10.1371/journal.pntd.0002729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953064/
https://www.ncbi.nlm.nih.gov/pubmed/24625516
http://dx.doi.org/10.1371/journal.pntd.0002729

Ejemplares similares